Dark

TNXP
Tonix Pharmaceuticals Holding Corp.
stock NASDAQ

At Close

Jan 23, 2026 3:59:49 PM EST

18.34USD-3.524%(-0.67)444,738

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jan 23, 2026 9:03:30 AM EST

19.02USD+0.031%(+0.01)1,030

After-hours

Jan 23, 2026 4:25:30 PM EST

18.68USD+1.854%(+0.34)704

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

234.28M

CEO

Seth Lederman

Headquarters

New York, USA

Industry

Biotechnology

Next Earnings

Mar 17, 2026 (50d)

Last Split

Feb 5, 20251for100reverse

ARQL SUPN PRGO AGRX XLV

TNXP Stats

Avg. Vol. 10 Day

444,825

Avg. Vol. 30 Day

477,747

Employees

Market Cap

234,277,424

Shares Out.

12,788,069

On/Off Exchange

51%/49%

6 Month Beta

2.68

1 Year Beta

0.99

2 Year Beta

1.07

3 Year Beta

1.12

52 Week Low

6.76

52 Week High

69.97

SMA50

16.94

SMA200

26.70

1 Week

+7.51%

1 Month

+12.67%

3 Month

-6.00%

6 Month

-63.16%

1 Year

-52.18%

2 Year

-98.15%

5 Year

-100.00%

Profile

tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage, designed as a daytime treatment for ptsd and tnx-801, a live synthetic version of horsepox virus, at the pre-ind application stage, to be developed as a potential smallpox-preventing vaccine. further information about tonix can be found at www.tonixpharma.com.

TNXP Stock Summary

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stock price today is $18.34, and today's volume is 444,738. TNXP is down -3.524% today. The 30 day average volume is 477,747. TNXP market cap is 234.28M with 12,788,069 shares outstanding.